PSI CRO AG is a contract research organization (CRO) that plans and manages Phase 2 and Phase 3 clinical trials. Services include study planning, feasibility analysis, site selection and trial execution across therapeutic areas such as oncology, gastroenterology, hematology, cell and gene therapy, neurology, infectious diseases and radiopharmaceuticals, and the company provides feasibility and site‑intelligence platforms (PSI Visional, PSI Synetic).
AI-generated
Offering
Products & services
Industry:Medical Laboratories
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Clinical research outsourcing for biopharma sponsors, including study conduct, adherence to timelines, enrollment through phase 2/3, and support with budget and project requirements.
Study management and conduct
Study management and conduct with a focus on timely project execution, rapid recruitment, study setup, close-out, and operational support for clinical trials.
Patient recruitment and enrollment management
Patient recruitment and enrollment management for clinical studies, including rapid enrollment rates and reaching enrollment milestones in phase 2 and phase 3 studies.
Consulting and proposal submission for clinical projects
Consulting and proposal submission for clinical projects via outreach and RFP submission, including review of timeline and requirements frameworks.
Knowledge
No knowledge articles yet
Once PSI CRO AG has claimed this profile, we'll publish editorial articles and case studies here together.